A Cursory Review of Casirivimab and Imdevimab for COVID-19
www.pulmccm.org
Jon-Emile S. Kenny MD [@heart_lung] "Booksellers are the most valuable destination for the lonely, given the numbers of books that were written because authors couldn't find anyone to talk to." - Alain de Botton Introduction An important reason for treating both tuberculosis and HIV with multiple pharmacological agents is the ability of these infectious scourges to mutate and escape monotherapy – thereby selecting a new variant resistant to medicinal weaponry. While escape mutants might be considered a problem specific to small molecules like antimicrobials, it is also true for, comparatively large, monoclonal antibodies.
A Cursory Review of Casirivimab and Imdevimab for COVID-19
A Cursory Review of Casirivimab and Imdevimab…
A Cursory Review of Casirivimab and Imdevimab for COVID-19
Jon-Emile S. Kenny MD [@heart_lung] "Booksellers are the most valuable destination for the lonely, given the numbers of books that were written because authors couldn't find anyone to talk to." - Alain de Botton Introduction An important reason for treating both tuberculosis and HIV with multiple pharmacological agents is the ability of these infectious scourges to mutate and escape monotherapy – thereby selecting a new variant resistant to medicinal weaponry. While escape mutants might be considered a problem specific to small molecules like antimicrobials, it is also true for, comparatively large, monoclonal antibodies.